Anti-remodelling drugs for the treatment of asthma: requirement for animal models of airway wall remodelling.

scientific article

Anti-remodelling drugs for the treatment of asthma: requirement for animal models of airway wall remodelling. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1046/J.1440-1681.1999.03494.X
P698PubMed publication ID11473527

P50authorAlastair StewartQ63373438
P2093author name stringD J Fernandes
K F Xu
P433issue8
P921main subjectasthmaQ35869
P304page(s)619-629
P577publication date2001-08-01
P1433published inClinical and Experimental Pharmacology and PhysiologyQ5133807
P1476titleAnti-remodelling drugs for the treatment of asthma: requirement for animal models of airway wall remodelling
P478volume28

Reverse relations

cites work (P2860)
Q46861382Airway goblet cell hyperplasia in asthma: hypersecretory and anti-inflammatory?
Q35093296MicroRNA-10a controls airway smooth muscle cell proliferation via direct targeting of the PI3 kinase pathway
Q64072479Modeling the pasture-associated severe equine asthma bronchoalveolar lavage fluid proteome identifies molecular events mediating neutrophilic airway inflammation
Q34754688New asthma targets: recent clinical and preclinical advances
Q35127841Recurrent airway obstruction--heaves
Q36474311The role of oxidative stress in an equine model of human asthma
Q36312384What is the contribution of respiratory viruses and lung proteases to airway remodelling in asthma and chronic obstructive pulmonary disease?